Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: A randomised comparative study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 4, 2008, Pages 415-417

  Ashkenazi, Avi ^a   Matro, R ^a   Shaw, J W ^b   Abbas, M A ^a   Silberstein, S D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LIDOCAINE; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; MALE; NECK PAIN; NERVE BLOCK; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TRANSFORMED MIGRAINE;

ADULT; ANESTHETICS, LOCAL; ANTI-INFLAMMATORY AGENTS; BUPIVACAINE; CRANIAL NERVES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SPINAL; LIDOCAINE; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NERVE BLOCK; PAIN MEASUREMENT; SPINAL NERVE ROOTS; TRIAMCINOLONE;

EID: 41149147042     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.124420     Document Type: Article

References (17)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257-70.
2. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996;47:871-5.
3. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med 2006;354:158-65.
4. Ward JB. Greater occipital nerve block. Semin Neurol 2003;23:59-62.
5. Shields KG, Levy MJ, Goadsby PJ. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology 2004;63:2193-4.
6. Lavin PJ, Workman R. Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids. Headache 2001;41:902-4.
7. Headache Classification Committee. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004;24:1-160.
8. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002;125:1496-509.
9. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Referred pain after painful stimulation of the greater occipital nerve in humans: evidence of convergence of cervical afferences on trigeminal nuclei. Cephalalgia 2001;21:107-9.
10. Caputi CA, Firetto V. Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 1997;37:174-9.
11. Gawel MJ, Rothbart PJ. Occipital nerve block in the management of headache and cervical pain. Cephalalgia 1992;12:9-13.
12. Peres MF, Stiles MA, Siow HC, et al. Greater occipital nerve blockade for cluster headache. Cephalalgia 2002;22:520-2.
13. Bovim G, Sand T. Cervicogenic headache, migraine without aura and tension-type headache. Diagnostic blockade of greater occipital and supra-orbital nerves. Pain 1992;51:43-8.
14. Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005;118:92-6.
15. Afridi SK, Shields KG, Bhola R, et al. Greater occipital nerve injection in primary headache syndromes - prolonged effects from a single injection. Pain 2006;122:126-9.
16. Cook BL, Malik SN, Shaw JW, et al. Greater occipital nerve (GON) block successfully treats migraine within five minutes. Neurology 2006;66:A42.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, NJ: Lawrence Earlbaum Associates, 1988.